Literature DB >> 29178448

Expanding the Clinical Spectrum of Phenotypes Caused by Pathogenic Variants in PLOD2.

Gabriela Ferraz Leal1,2, Gen Nishimura3, Ulrika Voss4, Débora Romeo Bertola5,6, Eva Åström7,8, Johan Svensson9, Guilherme Lopes Yamamoto5,6, Anna Hammarsjö10,11, Eva Horemuzova8,12, Nikos Papadiogannakis13, Erik Iwarsson10,11, Giedre Grigelioniene10,11, Emma Tham10,11.   

Abstract

Osteogenesis imperfecta (OI) is a strikingly heterogeneous group of disorders with a broad range of phenotypic variations. It is also one of the differential diagnoses in bent bone dysplasias along with campomelic dysplasia and thanatophoric dysplasia and can usually be distinguished by decreased bone mineralization and bone fractures. Bent bone dysplasias also include syndromes such as kyphomelic dysplasia (MIM:211350) and mesomelic dysplasia Kozlowski-Reardon (MIM249710), both of which have been under debate regarding whether or not they are a real entity or simply a phenotypic manifestation of another dysplasia including OI. Bruck syndrome type 2 (BRKS2; MIM:609220) is a rare form of autosomal recessive OI caused by biallelic PLOD2 variants and is associated with congenital joint contractures with pterygia. In this report, we present six patients from four families with novel PLOD2 variants. All cases had multiple fractures. Other features ranged from prenatal lethal severe angulation of the long bones as in kyphomelic dysplasia and mesomelic dysplasia Kozlowski-Reardon through classical Bruck syndrome to moderate OI with normal joints. Two siblings with a kyphomelic dysplasia-like phenotype who were stillborn had compound heterozygous variants in PLOD2 (p.Asp585Val and p.Ser166*). One infant who succumbed at age 4 months had a bent bone phenotype phenotypically like skeletal dysplasia Kozlowski-Reardon (with mesomelic shortening, camptodactyly, retrognathia, cleft palate, skin dimples, but also with fractures). He was homozygous for the nonsense variant (p.Trp561*). Two siblings had various degrees of Bruck syndrome caused by the homozygous missense variant, p.His687Arg. Furthermore a boy with a clinical presentation of moderate OI had a possibly pathogenic homozygous variant p.Trp588Cys. Our experience of six patients with biallelic pathogenic variants in PLOD2 expands the phenotypic spectrum in the PLOD2-related phenotypes.
© 2017 American Society for Bone and Mineral Research. © 2017 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BRUCK SYNDROME; KYPHOMELIC DYSPLASIA; MESOMELIC DYSPLASIA KOZLOWSKI-REARDON; OSTEOGENESIS IMPERFECTA; PLOD2; SKELETAL DYSPLASIA

Mesh:

Substances:

Year:  2018        PMID: 29178448     DOI: 10.1002/jbmr.3348

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  10 in total

1.  Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation.

Authors:  Steven Mumm; Gary S Gottesman; Deborah Wenkert; Philippe M Campeau; Angela Nenninger; Margaret Huskey; Vinieth N Bijanki; Deborah J Veis; Aileen M Barnes; Joan C Marini; Marina Stolina; Fan Zhang; William H McAlister; Michael P Whyte
Journal:  Bone       Date:  2019-08-28       Impact factor: 4.398

2.  A timeseries analysis of the fracture callus extracellular matrix proteome during bone fracture healing.

Authors:  Christopher B Erickson; Ryan Hill; Donna Pascablo; Galateia Kazakia; Kirk Hansen; Chelsea Bahney
Journal:  J Life Sci (Westlake Village)       Date:  2021-12

3.  COL1A2 p.Gly1066Val variant identified in a Han Chinese family with osteogenesis imperfecta type I.

Authors:  Mingyuan Wang; Yi Guo; Pengfei Rong; Hongbo Xu; Lina Gong; Hao Deng; Lamei Yuan
Journal:  Mol Genet Genomic Med       Date:  2019-03-04       Impact factor: 2.183

4.  Abnormal Bone Collagen Cross-Linking in Osteogenesis Imperfecta/Bruck Syndrome Caused by Compound Heterozygous PLOD2 Mutations.

Authors:  Charlotte Gistelinck; MaryAnn Weis; Jyoti Rai; Ulrike Schwarze; Dmitriy Niyazov; Kit M Song; Peter H Byers; David R Eyre
Journal:  JBMR Plus       Date:  2021-01-03

5.  Case Report: Exome Sequencing Identified a Novel Compound Heterozygous Variation in PLOD2 Causing Bruck Syndrome Type 2.

Authors:  Jing Zhang; Huaying Hu; Weihong Mu; Mei Yu; Wenqi Chen; Dongqing Mi; Kai Yang; Qing Guo
Journal:  Front Genet       Date:  2021-02-16       Impact factor: 4.599

6.  Genetic Analysis and Functional Study of a Pedigree With Bruck Syndrome Caused by PLOD2 Variant.

Authors:  Ruo-Li Wang; Dan-Dan Ruan; Ya-Nan Hu; Yu-Mian Gan; Xin-Fu Lin; Zhu-Ting Fang; Li-Sheng Liao; Fa-Qiang Tang; Wu-Bing He; Jie-Wei Luo
Journal:  Front Pediatr       Date:  2022-05-06       Impact factor: 3.418

7.  Whole Exome Sequencing in Two Southeast Asian Families With Atypical Femur Fractures.

Authors:  Wei Zhou; Hanh H Nguyen; Denise M van de Laarschot; Tet Sen Howe; Joyce S B Koh; Frances Milat; Jeroen G J van Rooij; Joost A M Verlouw; Bram C J van der Eerden; Mark Stevenson; Rajesh V Thakker; M Carola Zillikens; Peter R Ebeling
Journal:  JBMR Plus       Date:  2022-07-03

Review 8.  Collagen transport and related pathways in Osteogenesis Imperfecta.

Authors:  Lauria Claeys; Silvia Storoni; Marelise Eekhoff; Mariet Elting; Lisanne Wisse; Gerard Pals; Nathalie Bravenboer; Alessandra Maugeri; Dimitra Micha
Journal:  Hum Genet       Date:  2021-06-24       Impact factor: 4.132

9.  Molecular architecture of the multifunctional collagen lysyl hydroxylase and glycosyltransferase LH3.

Authors:  Luigi Scietti; Antonella Chiapparino; Francesca De Giorgi; Marco Fumagalli; Lela Khoriauli; Solomon Nergadze; Shibom Basu; Vincent Olieric; Lucia Cucca; Blerida Banushi; Antonella Profumo; Elena Giulotto; Paul Gissen; Federico Forneris
Journal:  Nat Commun       Date:  2018-08-08       Impact factor: 14.919

10.  High diagnostic yield in skeletal ciliopathies using massively parallel genome sequencing, structural variant screening and RNA analyses.

Authors:  Anna Lindstrand; Giedre Grigelioniene; Anna Hammarsjö; Maria Pettersson; David Chitayat; Atsuhiko Handa; Britt-Marie Anderlid; Marco Bartocci; Donald Basel; Dominyka Batkovskyte; Ana Beleza-Meireles; Peter Conner; Jesper Eisfeldt; Katta M Girisha; Brian Hon-Yin Chung; Eva Horemuzova; Hironobu Hyodo; Liene Korņejeva; Kristina Lagerstedt-Robinson; Angela E Lin; Måns Magnusson; Shahida Moosa; Shalini S Nayak; Daniel Nilsson; Hirofumi Ohashi; Naoko Ohashi-Fukuda; Henrik Stranneheim; Fulya Taylan; Rasa Traberg; Ulrika Voss; Valtteri Wirta; Ann Nordgren; Gen Nishimura
Journal:  J Hum Genet       Date:  2021-04-20       Impact factor: 3.172

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.